Evidence for the extent and oncological benefits of lymphadenectomy in colon and rectal cancer. A narrative review based on meta-analyses

被引:0
|
作者
Stelzner, Sigmar [1 ]
Lange, Undine Gabriele [1 ]
Rabe, Sebastian Murad [1 ]
Niebisch, Stefan [1 ]
Mehdorn, Matthias [1 ]
机构
[1] Univ Klinikum Leipzig, Klin Viszeral Transplantat Thorax & Gefasschirurg, Liebigstr 20, D-04103 Leipzig, Germany
来源
CHIRURGIE | 2025年
关键词
Low and high tie; Lateral pelvic lymphadenectomy; Longitudinal extent of resection; Infrapyloric and gastroepiploic lymph nodes; Sentinel node technique; LYMPH-NODE DISSECTION; COMPLETE MESOCOLIC EXCISION; TOTAL MESORECTAL EXCISION; COLORECTAL-CANCER; NEOADJUVANT CHEMORADIOTHERAPY; SURGERY; RESECTION; LIGATION; SURVIVAL; CARCINOMA;
D O I
10.1007/s00104-024-02212-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Lymphadenectomy for rectal cancer is clearly defined by total mesorectal excision (TME). The analogous surgical strategy for the colon, the complete mesocolic excision (CME), follows the same principles of dissection in embryologically predefined planes. Method: This narrative review initially identified key issues related to lymphadenectomy of rectal and colon cancer. The subsequent search was based on PubMed and focused on meta-analyses. The endpoints for rectal cancer were the benefit of high tie versus low tie and the indications for lateral pelvic lymphadenectomy. For colon cancer the evidence for CME, for the longitudinal extent of resection, for the dissection of infrapyloric and gastroepiploic lymph nodes, for the number of lymph nodes and for the sentinel lymph node technique were used as endpoints. Results: An oncological benefit of the high tie cannot be derived from the current data. Lateral pelvic lymphadenectomy should only be selectively performed after chemoradiotherapy (CRT) in cases of remaining lymph nodes with suspected metastases. In most studies CME proved to be oncologically superior, especially in stage III. The longitudinal extent of resection should be at least 10 cm in both directions if the principles of CME are observed. Infrapyloric and gastroepiploic lymph node involvement is to be expected in 0.7-22% of cases, depending on patient selection, which justifies dissection, particularly in carcinomas of both flexure and the transverse colon. The minimum number of lymph nodes to be removed cannot be clearly derived from the available studies. Precisely performed CME and an optimal pathological work-up are important. The sentinel lymph node technique cannot currently be used as a criterion for limiting the extent of resection. Conclusion: Both TME and CME are reliable standards for the lymphadenectomy in colorectal carcinomas. A lymphadenectomy that goes beyond this is reserved for selected cases and is partly the subject of currently ongoing studies.
引用
收藏
页码:293 / 305
页数:13
相关论文
共 10 条
  • [1] Evidenz für Ausmaß und onkologischen Nutzen der Lymphadenektomie beim Kolon- und RektumkarzinomEin narratives Review basierend auf MetaanalysenEvidence for the extent and oncological benefits of lymphadenectomy in colon and rectal cancerA narrative review based on meta-analyses
    Sigmar Stelzner
    Undine Gabriele Lange
    Sebastian Murad Rabe
    Stefan Niebisch
    Matthias Mehdorn
    Die Chirurgie, 2025, 96 (4) : 293 - 305
  • [2] D3-lymphadenectomy enhances oncological clearance in patients with right colon cancer. Results of a meta-analysis
    Balciscueta, Zutoia
    Balciscueta, Izaskun
    Uribe, Natalia
    Pellino, Gianluca
    Frasson, Matteo
    Garcia-Granero, Eduardo
    Garcia-Granero, Alvaro
    EJSO, 2021, 47 (07): : 1541 - 1551
  • [3] An evidence-based medicine review of lymphadenectomy extent for gastric cancer
    Yang, Sun Hu
    Zhang, You Cheng
    Yang, Ke Hu
    Li, You Ping
    He, Xiao Dong
    Tian, Jin Hui
    Lv, Ting Hong
    Hui, Ying Hua
    Sharma, Neel
    AMERICAN JOURNAL OF SURGERY, 2009, 197 (02) : 246 - 251
  • [4] The Frequency of Urination Dysfunction in Patients Operated on for Rectal Cancer: A Systematic Review with Meta-Analyses
    Agustsdottir, Dagny Halla
    Oberg, Stina
    Christophersen, Camilla
    Oggesen, Birthe Thing
    Rosenberg, Jacob
    CURRENT ONCOLOGY, 2024, 31 (10) : 5929 - 5942
  • [5] Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses
    Van Rees, Jan M.
    Wullaert, Lissa
    Grueter, Alexander A. J.
    Derraze, Yassmina
    Tanis, Pieter J.
    Verheul, Henk M. W.
    Martens, John W. M.
    Wilting, Saskia M.
    Vink, Geraldine
    Van Vugt, Jeroen L. A.
    Beije, Nick
    Verhoef, Cornelis
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] An evidence-based medicine review of lymphadenectomy extent for gastric cancer
    Slim, Karem
    Vons, Corinne
    AMERICAN JOURNAL OF SURGERY, 2009, 198 (04) : 580 - 580
  • [7] Lifestyle-based risk prediction models for colorectal cancer in a European population: a systematic review and meta-analyses
    Mertens, Elly
    Keuchkarian, Maria
    Colizzi, Chiara
    Vasquez, Maria Salve
    Cottam, James
    Penalvo, Jose Luis
    ANNALS OF NUTRITION AND METABOLISM, 2023, 79 : 350 - 350
  • [8] Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: A narrative review and evidence-based algorithm
    Borelli, Beatrice
    Germani, Marco Maria
    Carullo, Martina
    Mattioni, Roberto
    Manfredi, Bruno
    Sainato, Aldo
    Rossi, Piercarlo
    Vagli, Paola
    Balestri, Riccardo
    Buccianti, Piero
    Morelli, Luca
    Antoniotti, Carlotta
    Cremolini, Chiara
    Masi, Gianluca
    Moretto, Roberto
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 186
  • [9] Risk and Influencing Factors for Subsequent Primary Lung Cancer After Treatment of Breast Cancer: A Systematic Review and Two Meta-Analyses Based on Four Million Cases
    Wang, Yan
    Li, Jialong
    Chang, Shuai
    Dong, Yingxian
    Che, Guowei
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (11) : 1893 - 1908
  • [10] Total neoadjuvant treatment, non-operative management and radiotherapy-free strategies: New approaches for the management of proficient mismatch repair/microsatellite stable locally advanced rectal cancer. A narrative review and evidence-based algorithm
    Moretto, Roberto
    Boccaccio, Chiara
    Landi, Matteo
    Masi, Gianluca
    Cremolini, Chiara
    EUROPEAN JOURNAL OF CANCER, 2025, 218